Cowen’s Q2 Insights: Gilead Sciences, Inc., GW Pharmaceuticals PLC- ADR, Ariad Pharmaceuticals, Inc.
July 20, 2015 at 09:20 AM EDT
Second quarter earnings season is upon us and Cowen & Co. is counting on the biotechnology sector to deliver.
